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Abstract: (1) Background: Malnutrition is prevalent in hemodialysis (HD) patients and is associated
with an increased risk of morbidity and mortality. The aim of this study was to explore the prevalence
of malnutrition using the malnutrition-inflammation score (MIS) and phase angle (PhA) and compare
their concordance with the new Global Leadership Initiative on Malnutrition (GLIM) criteria for
the diagnosis of malnutrition. (2) Methods: Seventy HD patients were assessed. Malnutrition was
diagnosed based on the GLIM criteria and MIS questionnaire. The agreement between the diagnostic
tools (MIS, PhA derived from the bioelectrical impedance analysis (BIA), and GLIM criteria) was
assessed. The optimal gender-specific cutoff points were identified for the PhA according to the
GLIM criteria. (3) Results: Almost half of the sample was diagnosed as malnourished according to
the MIS (48.57%) and GLIM criteria (54.29%). A fair agreement was observed between the GLIM
criteria, MIS (k = 0.202), and PhA (k = 0.279) among the malnourished patients. The PhA had better
sensitivity but worse specificity compared to the MIS. The optimum cutoff points of PhA to detect
malnutrition according to the GLIM criteria were a PhA value of ≤5.7◦ for males and ≤3.8◦ for females.
(4) Conclusion: The MIS performed slightly better than PhA in the diagnosis of malnutrition among
HD patients within the spectrum of the GLIM criteria.
Keywords: malnutrition; malnutrition-inflammation score; phase angle; Global Leadership Initiative
on Malnutrition

1. Introduction
Malnutrition in hemodialysis (HD) is a well-established condition and often co-exists with
inflammation [1]. Between 50% to 75% of HD patients show signs of the malnutrition-inflammation
complex syndrome (MICS) depending on the diagnostic tool used [2]. This syndrome is closely
associated with adverse patient outcomes such as frailty, depression, higher morbidity and mortality,
and worsened quality of life (QoL) [2,3]. The global outcome is a vicious cycle of MICS and its
consequences, leading to chronicity [2]. Accordingly, a careful and periodic nutritional screening,
coupled with a timely diagnosis and the close monitoring of nutritional status, are cornerstones for
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implementing tailored interventions for the prevention and treatment of MICS [2]. This necessitates
the early identification of nutritional risk with tools that are accurate and sensitive [4,5].
Traditionally, the tools employed to detect MICS in HD patients ranged from anthropometry,
to biochemical parameters, and numerous composite scores parallel to clinical judgment [6–8]. Among
the latter, the malnutrition-inflammation score (MIS) emerged as a comprehensive quantitative scoring
system for diagnosing MICS [1,9–11]. However, its use in clinical practice requires an interview
with the patient, a thorough physical examination of subcutaneous body fat and signs of muscle
wasting, in addition to biochemical variables including serum albumin level, total iron-binding capacity
(TIBC), or transferrin level [9]. Within the time constraints reported among renal dietitians [12], there
is a pressing need for an accurate, easy-to-use, and cost-effective diagnostic tool. In recent years,
bioelectrical impedance analysis (BIA)-derived phase angle (PhA) has gained attention in this regard,
especially since the Academy of Nutrition and Dietetics stated that the use of BIA is appropriate in
chronic kidney disease (CKD) patients [13]. PhA is proportional to the ratio of reactance and resistance
between body cell mass and fat-free mass [14], and is assumed to indicate cell integrity [15]. In various
clinical fields, PhA was shown to be a reliable marker for the detection of early malnutrition [16,17].
The primary aim of this study was to explore the prevalence of malnutrition in a sample of HD
patients in a hospital-based dialysis unit in the United Arab Emirates (UAE) using the MIS and BIA,
and compare them with the new Global Leadership Initiative on Malnutrition (GLIM) criteria for the
diagnosis of malnutrition. The secondary aim was to find out the gender-specific cutoff point of PhA
for the studied population.
2. Materials and Methods
2.1. Study Design
A cross-sectional study was conducted in September 2017 in a randomly chosen tertiary
hospital-based HD unit in the UAE. The study protocol was designed in accordance with the
Helsinki Ethical Declaration. The study was registered at ClinicalTrials.gov (ID: NCT03131804). The
study belongs to a larger clinical trial for which the trial protocol was previously published [18]. Ethical
approval was obtained from Zayed University and the Ministry of Health and Prevention (MOHP). All
eligible and consenting patients receiving HD in the unit were recruited to the study. Due to the lack of
official renal registry in the UAE, we were unable to obtain the total number of HD patients. Thus, a
power analysis could not be carried out. The eligible candidates were stable adult patients on HD, free
of acute diseases (cancer, active infections, myocardial infarction, and acute pulmonary diseases), who
had not been hospitalized in the past 6 months, and were willing to participate in the study. Patients
who were fitted with a heart pacemaker, pregnant, or did not meet the inclusion criteria were excluded.
All patients who consented also completed the study. All demographic and clinical data were collected
from the electronic medical records. Initially, the original trial was planned to be a multicenter trial.
However, we obtained ethical approval to only one center excluding patients with hepatopathy. Thus,
the study was performed in one center.
2.2. Malnutrition-Inflammation Score (MIS)
The MIS is a validated tool frequently used for assessing the malnutrition-inflammation status of
patients. This is a composite score of 10 components, each with four levels of severity ranging from 0
(normal) to 3 (severely abnormal). The scoring sheet is composed of four sections: (1) patients’ related
medical history including weight change in edema-free post-HD body weight in the past 6 months,
dietary intake, gastrointestinal symptoms, functional capacity, and comorbidities; (2) physical exam of
subcutaneous body fat and signs of muscle wasting according to the Subjective Global Assessment
(SGA) criteria; (3) body mass index (BMI); and (4) laboratory parameters, i.e., serum albumin level and
TIBC [9]. The sum of all components ranges from 0 (normal) to 30 (severely abnormal). A higher score
reflects a more severe degree of malnutrition and inflammation. The assessment was performed by
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trained dietitians at the end of the HD session. To avoid bias in the collection of data, the dietitians
who conducted the MIS were different from those who conducted the BIA.
2.3. Malnutrition Using the Global Leadership Initiative on Malnutrition (GLIM) Criteria
In 2018, the Global Leadership Initiative on Malnutrition (GLIM) criteria were introduced [19].
GLIM is a two-step approach for malnutrition diagnosis. The first step incorporates initial screening
with any validated screening tool in order to identify “at risk” patients. The second step is the
assessment for the diagnosis and grading of the severity of malnutrition. The assessment criteria for
malnutrition include the phenotypic criteria: (1) non-volitional weight loss (weight loss of > 5% within
the past 6 months); (2) low BMI (< 20 kg/m2 if < 70 years and < 22 kg/m2 if ≥ 70 years); (3) reduced
muscle mass (fat-free mass index (FFMI)of < 17 kg/m2 for males and < 15 kg/m2 for females) [20]; and
(4) two etiologic criteria consisting of reduced food intake and inflammation or disease burden. To
diagnose malnutrition, at least one phenotypic and one etiologic criterion should be present. For this
study, we assessed the non-volitional weight loss based on the previous European Society for Parenteral
and Enteral Nutrition (ESPEN) recommendation, which is >5% within the last 3 months, because
these were the published recommendations at data collection point [20]. Furthermore, the phenotypic
grading of malnutrition was described as Stage 1 (moderate) and Stage 2 (severe) malnutrition [19]
using the sarcopenia cutoff points for low muscle quantity, where patients with low appendicular
muscle mass (ASM) (< 20 kg in males and < 15 kg in females) were classified as Stage 2 malnourished
patients. Higher or equal ASM values were indicated as Stage 1 malnutrition. ASM was derived from
the skeletal muscle mass (SMM) measured by the BIA [21], and the cutoff points were taken from
the consensus of the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) [21].
Furthermore, fat mass index (FMI) was measured independently of GLIM for the sake of finding
potential patients with high adiposity coupled with low muscle mass. Different studies reported a
range of cutoff points, the highest numbers being FMI ≥7 kg/m2 for males and 9.5 kg/m2 for females,
as indicative of metabolic syndrome [22–24].
2.4. Phase Angle (PhA)
The reaction of the body to an electric current when using a BIA comprises two components: (1)
resistance, which is the restriction to the electrical current flow due to extracellular water (ECW) and
intracellular water (ICW); and (2) reactance, which is the resistive effect of the body tissues and cell
membranes. PhA is a parameter that reflects the amount of reactance in the human body relative to the
amount of resistance. PhA is calculated based on the following formula: reactance/resistance*180/π [14].
PhA decreases with increased inflammation/disease severity [25] and age [26]. In the current study,
BIA was performed using the SECA (mBCA 525-Germany) device in a supine position according to the
ESPEN guidelines on BIA application [27]. The device analyzed body composition through 8 points of
contact where two electrodes were connected to each of the right and left arm and leg. Patients with a
voided bladder were assessed within 10 minutes after the HD session according to the manufacturer’s
recommendations. The standardized PhA value, adjusted for the age and gender of the patient, was
directly generated by the BIA. Height was measured in the clinic during the session and integrated in
the data of the BIA machine.
2.5. Statistical Analysis
The collected data were analyzed using IBM SPSS Statistics 21.0 package. Descriptive analysis
was used to summarize the study variables and to check for out-of-range values. Kolmogorov-Smirnov
tests were used to assess data normality. The categorical variables were described using frequencies
and percentages, while means and standard deviations were used to represent the normally distributed
continuous variables. The medians and interquartile range (IQR) values were used for skewed data.
Pearson’s correlation coefficient was used to examine the relationship between the MIS and PhA.
The concordance of the MIS and PhA were analyzed using the MedCalc software. Further analysis was
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done to detect which of these assessors predicted malnutrition best based on the GLIM criteria. Thus,
the area under the curve (AUC) based on receiver operating characteristic (ROC) statistics [28] and the
positive and negative likelihood ratios (LR+ and LR− respectively) were calculated. An area under the
ROC curve equal to 0.5 indicates that a tool could not distinguish between the two groups. When equal
to 1, it indicates perfect separation of the values of the two groups. Furthermore, sensitivity, specificity,
positive and negative predictive values, and likelihood ratios were calculated. Two-tailed p ≤ 0.05
was reported for all statistical tests. To assess the agreement between the old and new malnutrition
assessors, Cohen’s kappa (κ) was used to compare (1) a newly established malnutrition criteria (the
GLIM criteria) with an already established tool (MIS); and (2) the GLIM criteria with a newly emerging
criteria (PhA) with κ ranges from −1 to +1. Based on the guidelines from Altman, a κ < 0.2 represents
a poor strength of agreement, and 0.21 < κ < 0.40, 0.41 < κ < 0.60, 0.61 < κ < 0.80, and 0.81 < κ <
1.00 represent a fair, moderate, good, and very good agreement respectively. Finally, the positive
predictive value (PPV), negative predictive value (NPV), and the likelihood ratios were used to study
the concordance of the GLIM criteria with the MIS (>10) and PhA (≤5.7◦ ). The latter was identified
in this study as the cutoff point for the general sample. Below this, the PhA indicated malnutrition.
These measures were included as they are important in public health and health planning [29].
3. Results
3.1. Patients’ Characteristics
Seventy adult HD patients were included in the study. The mean age was 54.61 ± 12.79 years and
the mean BMI was 27.22 ± 6.48 kg/m2 . Hypertension was the most common comorbidity (88.57%),
followed by diabetes (65.71%) and cardiovascular diseases (40.00%). The descriptive data of the sample
are presented in Table 1.
The mean MIS of the participants was 9.40 ± 3.07 and SMM was within normal values, however
the FFMI indicated low muscle mass and borderline malnourishment (males: 15.08 ± 2.74; and females
17.90 ± 3.44). Fat mass index was indicative of excess fat and only 2.9% of the sample had low FMI.
Finally, the mean of the BIA-derived PhA was 4.66 ± 1.21◦ . The latter was analyzed for 69 patients due
to one item of missing patient data.
Almost half of the sample was identified to be malnourished with the MIS (48.57%) and GLIM
criteria (54.29%). Further analysis using the GLIM criteria staging showed that almost 70% of the
malnourished were actually severely malnourished.
3.2. Concordance of GLIM with MIS and PhA
The area under the curve based on ROC curve statistics was presented in Figure 1. The identified
cutoff points of PhA according to the GLIM criteria for the whole sample was PhA ≤ 5.7◦ (males: ≤5.7◦ ;
females: ≤3.8◦ ). As for the MIS, the cutoff point of MIS > 10, retrieved from the literature, was used [9].
The MIS seemed to be slightly better correlated with the GLIM criteria according to the AUC
compared with the PhA (AUCMIS = 0.691, confidence interval = 0.569–0.796, p = 0.003, vs. AUCPhA =
0.614, confidence interval = 0.489–0.729, p = 0.104) (Figure 1). PhA had a better sensitivity (86.84%)
compared with the MIS (39.47%), but a worse specificity (35.48 vs. 71.87 respectively). The MIS was
found to have better LR+ and LR at the same time.
3.3. Strength of Agreement between the GLIM Criteria vs. the MIS, and the GLIM Criteria vs. PhA
The strength of agreement between the MIS and GLIM (Table 2) criteria in diagnosing malnutrition
according to Cohen’s kappa was fair and not statistically significant (κ = 0.202; p = 0.089). The strength
of agreement between the PhA and GLIM criteria in diagnosing malnutrition according to Cohen’s
kappa was fair and statistically significant (κ = 0.234; p = 0.029).

Nutrients 2019, 11, 2771

5 of 10

Table 1. Demographic and characteristics of study participants (n = 70).
Total n = 70
Mean (SD)
Age (years)

54.61 (12.79)

(kg/m2 )

27.22 (6.48)

(◦ )

4.66 (1.21)

BMI

PhA

MIS

9.40 (3.07)

(kg/m2 )

10.15 (5.00)

FMI

SMM (kg)

19.67 (6.44)

Fat (kg)

26.70 (12.57)
Median (IQR)

FFMI

(kg/m2 )

17.09 (3.33)

FFM (kg)

42.92 (15.14)

TBW (L)

32.15 (11.4)

ECW (L)

15.20 (4.7)
N (%)

Gender: Male

43 (61.4)

Comorbidities *
Diabetes
Hypertension
Cardiovascular Diseases
Others

46 (65.71)
62 (88.57)
28 (40.00)
37 (52.86)

Dialysis Vintage
<1 year
1–4 years
>4 years

5 (7.14)
35 (50.00)
30 (42.86)

Malnourished as per GLIM Criteria

38 (54.29)

Stage 1: Moderate Malnutrition

12 (31.58)

Stage 2: Severe Malnutrition

26 (68.42)

Malnourished as per the MIS (>10)

34 (48.57)

BMI: body mass index; PhA: phase angle; MIS: malnutrition-inflammation score; FMI: fat mass index; SMM: skeletal
muscle mass; FFMI: fat-free mass index; TBW: total body water; ECW: extracellular water; GLIM: Global Leadership
Initiative on Malnutrition; SD: standard deviation; IQR: interquartile range. * Percentages do not sum up due to
aggregated error from multiple answers. PhA was analyzed for 69 patients. Cutoff points for malnutrition: MIS
(>10); SMM (males < 0 kg; females < 15 kg); FMI (males <1.2 kg/m2 ; females < 3.8 kg/m2 ); FFMI (males < 17 kg;
females < 15 kg).

Table 2. Concordance of the GLIM criteria with the MIS (>10) and PhA (≤5.7◦ ).
Criterion

MIS > 10

PhA ≤ 5.7◦

Sensitivity (%)
Specificity (%)
Positive predictive value (%)
Negative predictive value (%)
Positive likelihood ratio (LR+)
Negative likelihood ratio (LR−)
K value (p)
Area under the curve (AUC)

39.47
71.87
50.0
62.5
1.40
0.84
0.202 (0.089)
0.691

86.84
35.48
62.63
68.68
1.35
0.37
0.234 (0.029)
0.614
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4. Discussion
To our best knowledge, this is the first study that has identified the prevalence of malnutrition
among a selected group of HD patients in the UAE while assessing the concordance of the BIA-derived
PhA (a holistic assessment tool) and MIS (an established assessment tool) with the GLIM diagnostic
criteria for malnutrition.
This study identified almost half of the HD patients as malnourished using the MIS and
showed a concordance between the two assessors. Alarmingly, most of these patients were also
severely malnourished.
There was a fair agreement for both assessors with the GLIM criteria and it was statistically
significant for PhA but not MIS. The reasons for the lack of stronger agreement can be attributed to
the small sample size. Moreover, the lack of strong agreement between the MIS and GLIM criteria
may be due to the fact that GLIM assessed muscle mass using objective measures whereas the MIS
used subjective ones. Since PhA is BIA-derived and fully objective, we conducted a further analysis to
identify the specific cutoff points for PhA of malnutrition in the general population. The angle at 5.7◦
and below showed to be the indicator for malnutrition. The specificity and sensitivity of PhA to GLIM
was seen to be optimal at 5.7◦ for males and 3.8◦ for females. These numbers might be considered
as possible cutoff points to screen HD patients for malnutrition. In another setting, different cutoff
points for PhA appeared to be a useful in screening nutritional status among males (5.0◦ ) and females
(4.6◦ ) [16]. Moreover, our results were in line with the findings of Bansal [30], where they demonstrated
a PhA of <5.59◦ among chronic kidney disease patients to be associated with mortality.
Based on our analysis, PhA had higher sensitivity than the MIS using the GLIM criteria as a
reference standard. This means that PhA can lead to a greater number of diagnosis of malnourished
cases when compared to the MIS. In fact, metabolic changes in cell membranes are first affected by
malnutrition [31]. As PhA reflects on cell integrity, it could detect malnutrition at an early stage.
Unfortunately, when the malnutrition-inflammation syndrome complex (MISC) develops in the patient,
it forms a vicious cycle that is difficult to treat; thus, measuring the PhA may be a tool to prevent MISC
from being established.
In addition, the AUC suggested that, clinically, the MIS achieved better performance than PhA
in identifying malnutrition in HD patients since it was more sensitive, and the AUC curve with the
GLIM criteria resulted in statistically significant results. It must be noted that the difference between
the AUC of the MIS and PhA with the GLIM criteria was <0.08, denoting almost similar diagnostic
capabilities when it came to the whole sample. With the current results, we concluded that the MIS
should be used as a better diagnostic tool than PhA at this stage. This was expected since the MIS is a
tool especially designed for HD patients. In addition, the superiority of the MIS over the PhA might
be related to the small sample size we had. In fact, a recent review reported that PhA may not be an
accurate indicator of malnutrition [32]. However, PhA is a very new indicator and further research is
needed for its accuracy, appropriateness, and cutoff points, particularly in HD patients.
The literature is clear on the relationship of malnutrition and low muscle mass with higher
mortality [33]. Thus, our results may be used in interventions like improved protein intake and
physical exercise in HD patients to prolong longevity and increase QoL.
There were a few limitations to this study, such as the sample not being powerful enough to
detect the prevalence of malnutrition in the UAE and the use of a convenience selection sampling
technique. These limitations did not allow us to generalize our findings to the whole HD population in
the UAE. Finally, the assessments were based on a single measurement and this might have influenced
the results, knowing the nature of CKD and the health fluctuations that affect HD patients.
The overall results of this study can lead us to speculate that the clinical difference between PhA
and the MIS are not very far apart, and that both have their strengths and weaknesses. However, they
do not result in major differences for the clinician and the patient. Consequently, the current research
team invites future studies to look into larger samples for this patient subgroup and to validate the
clinical effectiveness of using PhA as a practical tool for malnutrition screening.
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5. Conclusions
Malnutrition is widespread in the HD population in the UAE. Clinically, in the current sample,
the MIS performed slightly better than PhA in the diagnosis of malnutrition when using the GLIM
criteria as a reference, but both tools may perform equally on a large sample. Prioritizing malnutrition
screening in this population and integrating cost-effective, sensitive, and specific tools within routine
practice is advocated as a result of the findings of this study.
Author Contributions: M.K.; conceptualization, funding acquisition, methodology, project administration,
resources, supervision; N.S.; investigation, visualization; R.R.; formal analysis, visualization; K.A.P.;
conceptualization; M.K., N.S., R.R., and K.A.P.; contributed to drafting and revising the article. All authors read
and approved the final version of the manuscript.
Funding: This work was supported by Zayed University, Dubai, UAE and SECA GMBH Co. & Kg, Dubai, UAE.
Acknowledgments: We would like to thank the SECAGMBH Co. & Kg Company and representatives for their
support. Also, our appreciation goes to the dietary department of Al Qassimi Hospital and the research assistants
for their assistance in data collection. Last, we thank the nursing staff and the participating HD patients for their
collaboration. Joelle Abi Kharma for advice on statistical analysis.
Conflicts of Interest: The authors declare that the article is original, is not under consideration for
publication anywhere else and has not been previously published. The authors declare no conflict of interest,
or financial disclosures.

References
1.

2.

3.

4.

5.

6.

7.

8.
9.

10.

Kalantar-Zadeh, K.; Kopple, J.D.; Humphreys, M.H.; Block, G. Comparing outcome predictability of markers
of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol. Dial. Transplant. 2004,
19, 1507–1519. [CrossRef] [PubMed]
Sabatino, A.; Regolisti, G.; Karupaiah, T.; Sahathevan, S.; Singh, B.K.S.; Khor, B.H.; Salhab, N.; Karavetian, M.;
Cupisti, A.; Fiaccadori, E. Protein-energy wasting and nutritional supplementation in patients with end-stage
renal disease on hemodialysis. Clin. Nutr. 2017, 36, 663–671. [CrossRef] [PubMed]
Ikizler, T.A.; Cano, N.J.; Franch, H.; Fouque, D.; Himmelfarb, J.; Kalantar-Zadeh, K.; Kuhlmann, M.K.;
Stenvinkel, P.; TerWee, P.; Teta, D.; et al. Prevention and treatment of protein energy wasting in chronic kidney
disease patients: A consensus statement by the International Society of Renal Nutrition and Metabolism.
Kidney Int. 2013, 84, 1096–1107. [CrossRef] [PubMed]
Poulia, K.A.; Klek, S.; Doundoulakis, I.; Bouras, E.; Karayiannis, D.; Baschali, A.; Passakiotou, M.;
Chourdakis, M. The two most popular malnutrition screening tools in the light of the new ESPEN consensus
definition of the diagnostic criteria for malnutrition. Clin. Nutr. 2017, 36, 1130–1135. [CrossRef]
Cederholm, T.; Barazzoni, R.; Austin, P.; Ballmer, P.; Biolo, G.; Bischoff, S.C.; Compher, C.; Correia, I.;
Higashiguchi, T.; Holst, M.; et al. ESPEN guidelines on definitions and terminology of clinical nutrition.
Clin. Nutr. 2017, 36, 49–64. [CrossRef]
Rogowski, L.; Kusztal, M.; Golebiowski, T.; Bulinska, K.; Zembron-Lacny, A.; Wyka, J.; Klinger, M.;
Wozniewski, M.; Dziubek, W. Nutritional assessment of patients with end-stage renal disease using the
MNA scale. Adv. Clin. Exp. Med. 2018, 27, 1117–1123. [CrossRef]
Da Silva, A.T.; Hauschild, D.B.; Moreno, Y.M.F.; Bastos, J.L.D.; Wazlawik, E. Diagnostic Accuracy of
Bioelectrical Impedance Analysis Parameters for the Evaluation of Malnutrition in Patients Receiving
Hemodialysis. Nutr. Clin. Pract. 2018, 33, 831–842. [CrossRef]
Garcia, M.F.; Wazlawik, E.; Moreno, Y.M.F.; Fhur, L.M.; Gonzalez-Chica, D.A. Diagnostic accuracy of handgrip
strength in the assessment of malnutrition in hemodialyzed patients. e-SPEN J. 2013, 8, e181–e186. [CrossRef]
Kalantar-Zadeh, K.; Kopple, J.D.; Block, G.; Humphreys, M.H. A malnutrition-inflammation score is
correlated with morbidity and mortality in maintenance hemodialysis patients. Am. J. Kidney Dis. 2001, 38,
1251–1263. [CrossRef]
Pisetkul, C.; Chanchairujira, K.; Chotipanvittayakul, N.; Ong-Ajyooth, L.; Chanchairujira, T. Malnutritioninflammation score associated with atherosclerosis, inflammation and short-term outcome in hemodialysis
patients. J. Med. Assoc. Thail. 2010, 93 (Suppl. 1), S147–S156.

Nutrients 2019, 11, 2771

11.

12.
13.
14.
15.

16.

17.

18.
19.

20.

21.

22.
23.
24.

25.
26.

27.

28.
29.
30.

9 of 10

Rambod, M.; Bross, R.; Zitterkoph, J.; Benner, D.; Pithia, J.; Colman, S.; Kovesdy, C.P.; Kopple, J.D.;
Kalantar-Zadeh, K. Association of Malnutrition-Inflammation Score with quality of life and mortality in
hemodialysis patients: A 5-year prospective cohort study. Am. J. Kidney Dis. 2009, 53, 298–309. [CrossRef]
[PubMed]
Wolfe, W.A. Moving the issue of renal dietitian staffing forward. J. Ren. Nutr. 2012, 22, 515–520. [CrossRef]
[PubMed]
The American Dietetic Association (ADA). Chronic Kidney Disease. In Evidence-Based Nutrition Practice
Guideline; The American Dietetic Association (ADA): Chicago, IL, USA, 2010.
Baumgartner, R.N.; Chumlea, W.C.; Roche, A.F. Bioelectric impedance phase angle and body composition.
Am. J. Clin. Nutr. 1988, 48, 16–23. [CrossRef] [PubMed]
Barbosa-Silva, M.C.; Barros, A.J. Bioelectrical impedance analysis in clinical practice: A new perspective on
its use beyond body composition equations. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8, 311–317. [CrossRef]
[PubMed]
Kyle, U.G.; Soundar, E.P.; Genton, L.; Pichard, C. Can phase angle determined by bioelectrical impedance
analysis assess nutritional risk? A comparison between healthy and hospitalized subjects. Clin. Nutr. 2012,
31, 875–881. [CrossRef] [PubMed]
Wiech, P.; Bazalinski, D.; Salacinska, I.; Binkowska-Bury, M.; Korczowski, B.; Mazur, A.; Kozka, M.;
Dabrowski, M. Decreased Bioelectrical Impedance Phase Angle in Hospitalized Children and Adolescents
with Newly Diagnosed Type 1 Diabetes: A Case-Control Study. J. Clin. Med. 2018, 7, 516. [CrossRef]
[PubMed]
Salhab, N.; Karavetian, M.; Kooman, J.; Fiaccadori, E. Intradialytic Aerobic Exercise in the United Arab
Emirates: A Descriptive Study. Arab J. Nutr. Exerc. 2018, 3, 18–34. [CrossRef]
Cederholm, T.; Jensen, G.L.; Correia, M.; Gonzalez, M.C.; Fukushima, R.; Higashiguchi, T.; Baptista, G.;
Barazzoni, R.; Blaauw, R.; Coats, A.J.S.; et al. GLIM criteria for the diagnosis of malnutrition—A consensus
report from the global clinical nutrition community. J. Cachexia Sarcopenia Muscle 2019, 10, 207–217. [CrossRef]
Cederholm, T.; Bosaeus, I.; Barazzoni, R.; Bauer, J.; Van Gossum, A.; Klek, S.; Muscaritoli, M.; Nyulasi, I.;
Ockenga, J.; Schneider, S.M.; et al. Diagnostic criteria for malnutrition—An ESPEN Consensus Statement.
Clin. Nutr. 2015, 34, 335–340. [CrossRef]
Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyere, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.;
Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019, 48,
16–31. [CrossRef]
Liu, P.; Ma, F.; Lou, H.; Liu, Y. The utility of fat mass index vs. body mass index and percentage of body fat
in the screening of metabolic syndrome. BMC Public Health 2013, 13, 629. [CrossRef] [PubMed]
Peltz, G.; Aguirre, M.T.; Sanderson, M.; Fadden, M.K. The role of fat mass index in determining obesity. Am.
J. Hum. Biol. 2010, 22, 639–647. [CrossRef] [PubMed]
Tomlinson, D.J.; Erskine, R.M.; Morse, C.I.; Onambele, G.L. Body Fat Percentage, Body Mass Index, Fat
Mass Index and the Ageing Bone: Their Singular and Combined Roles Linked to Physical Activity and Diet.
Nutrients 2019, 11, 195. [CrossRef] [PubMed]
Graf, C.E.; Herrmann, F.R.; Genton, L. Relation of Disease with Standardized Phase Angle among Older
Patients. J. Nutr. Health Aging 2018, 22, 601–607. [CrossRef] [PubMed]
Gonzalez, M.C.; Barbosa-Silva, T.G.; Bielemann, R.M.; Gallagher, D.; Heymsfield, S.B. Phase angle and its
determinants in healthy subjects: Influence of body composition. Am. J. Clin. Nutr. 2016, 103, 712–716.
[CrossRef]
Kyle, U.G.; Bosaeus, I.; De Lorenzo, A.D.; Deurenberg, P.; Elia, M.; Gomez, J.M.; Heitmann, B.L.; Kent-Smith, L.;
Melchior, J.C.; Pirlich, M.; et al. Bioelectrical impedance analysis-part II: Utilization in clinical practice. Clin.
Nutr. 2004, 23, 1430–1453. [CrossRef]
DeLong, E.R.; DeLong, D.M.; Clarke-Pearson, D.L. Comparing the areas under two or more correlated
receiver operating characteristic curves: A nonparametric approach. Biometrics 1988, 44, 837–845. [CrossRef]
Grunau, G.; Linn, S. Commentary: Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities,
and Pitfalls in Research and Practice. Front. Public Health 2018, 6, 256. [CrossRef]
Bansal, N.; Zelnick, L.R.; Himmelfarb, J.; Chertow, G.M. Bioelectrical Impedance Analysis Measures and
Clinical Outcomes in CKD. Am. J. Kidney Dis. 2018, 72, 662–672. [CrossRef]

Nutrients 2019, 11, 2771

31.
32.

33.

10 of 10

Barbosa-Silva, M.C. Subjective and objective nutritional assessment methods: What do they really assess?
Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 248–254. [CrossRef]
Rinaldi, S.; Gilliland, J.; O’Connor, C.; Chesworth, B.; Madill, J. Is phase angle an appropriate indicator of
malnutrition in different disease states? A systematic review. Clin. Nutr. ESPEN 2019, 29, 1–14. [CrossRef]
[PubMed]
Johansen, K.L.; Lee, C. Body composition in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2015, 24,
268–275. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).

